Bank of New York Mellon »

Trevi Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-09-30 $459k 137k 3.34
2024-06-30 $532k 179k 2.98
2024-03-31 $444k 129k 3.45
2023-12-31 $179k 133k 1.34
2023-09-30 $292k 134k 2.18
2023-06-30 $315k 132k 2.39
2023-03-31 $26k 14k 1.85
2022-12-31 $27k 14k 1.93
2022-09-30 $22k 14k 1.56